心筋虚血治療の世界市場（～2026年）

• 英文タイトル：Global Myocardial Ischemia Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03887
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は心筋虚血治療のグローバル市場について調査・分析したレポートです。種類別（医薬品、手術、その他）市場規模、用途別（病院、診療所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別心筋虚血治療の競争状況、市場シェア
・世界の心筋虚血治療市場：種類別市場規模 2015年-2020年（医薬品、手術、その他）
・世界の心筋虚血治療市場：種類別市場規模予測 2021年-2026年（医薬品、手術、その他）
・世界の心筋虚血治療市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター、その他）
・世界の心筋虚血治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター、その他）
・北米の心筋虚血治療市場分析：米国、カナダ
・ヨーロッパの心筋虚血治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの心筋虚血治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の心筋虚血治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの心筋虚血治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Novartis、AstraZeneca、Boston Scientific、Johnson & Johnson、Boehringer Ingelheim、Daiichi Sankyo、Merck、Edwards Lifesciences、Bayer、Gene Biotherapeutics、ViroMed
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Myocardial ischemia is a condition characterized by insufficient blood flow to the heart creating a paucity of oxygen leading to heart attacks. It is also known as cardiac ischemia and the blockage of coronary artery can cause abnormal heart rhythms.
The Americas are the flag-bearer, the region is going to dominate the global market during the forecast period.

Market Analysis and Insights: Global Myocardial Ischemia Treatment Market
The global Myocardial Ischemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Myocardial Ischemia Treatment Scope and Market Size
Myocardial Ischemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Myocardial Ischemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Novartis
AstraZeneca
Boston Scientific
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo
Merck
Edwards Lifesciences
Bayer
Gene Biotherapeutics
ViroMed

Market segment by Type, the product can be split into
Medications
Surgery
Others
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Myocardial Ischemia Treatment Revenue
1.4 Market by Type
1.4.1 Global Myocardial Ischemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medications
1.4.3 Surgery
1.4.4 Others
1.5 Market by Application
1.5.1 Global Myocardial Ischemia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Myocardial Ischemia Treatment Market Perspective (2015-2026)
2.2 Global Myocardial Ischemia Treatment Growth Trends by Regions
2.2.1 Myocardial Ischemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Myocardial Ischemia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Myocardial Ischemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Myocardial Ischemia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Myocardial Ischemia Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Myocardial Ischemia Treatment Players by Market Size
3.1.1 Global Top Myocardial Ischemia Treatment Players by Revenue (2015-2020)
3.1.2 Global Myocardial Ischemia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Myocardial Ischemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Myocardial Ischemia Treatment Market Concentration Ratio
3.2.1 Global Myocardial Ischemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Myocardial Ischemia Treatment Revenue in 2019
3.3 Myocardial Ischemia Treatment Key Players Head office and Area Served
3.4 Key Players Myocardial Ischemia Treatment Product Solution and Service
3.5 Date of Enter into Myocardial Ischemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Myocardial Ischemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Myocardial Ischemia Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Myocardial Ischemia Treatment Market Size by Application (2015-2020)
5.2 Global Myocardial Ischemia Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Myocardial Ischemia Treatment Market Size (2015-2020)
6.2 Myocardial Ischemia Treatment Key Players in North America (2019-2020)
6.3 North America Myocardial Ischemia Treatment Market Size by Type (2015-2020)
6.4 North America Myocardial Ischemia Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Myocardial Ischemia Treatment Market Size (2015-2020)
7.2 Myocardial Ischemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Myocardial Ischemia Treatment Market Size by Type (2015-2020)
7.4 Europe Myocardial Ischemia Treatment Market Size by Application (2015-2020)

8 China
8.1 China Myocardial Ischemia Treatment Market Size (2015-2020)
8.2 Myocardial Ischemia Treatment Key Players in China (2019-2020)
8.3 China Myocardial Ischemia Treatment Market Size by Type (2015-2020)
8.4 China Myocardial Ischemia Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Myocardial Ischemia Treatment Market Size (2015-2020)
9.2 Myocardial Ischemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Myocardial Ischemia Treatment Market Size by Type (2015-2020)
9.4 Japan Myocardial Ischemia Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Myocardial Ischemia Treatment Market Size (2015-2020)
10.2 Myocardial Ischemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Myocardial Ischemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Myocardial Ischemia Treatment Market Size by Application (2015-2020)

11 India
11.1 India Myocardial Ischemia Treatment Market Size (2015-2020)
11.2 Myocardial Ischemia Treatment Key Players in India (2019-2020)
11.3 India Myocardial Ischemia Treatment Market Size by Type (2015-2020)
11.4 India Myocardial Ischemia Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Myocardial Ischemia Treatment Market Size (2015-2020)
12.2 Myocardial Ischemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Myocardial Ischemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Myocardial Ischemia Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Myocardial Ischemia Treatment Introduction
13.1.4 Pfizer Revenue in Myocardial Ischemia Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Myocardial Ischemia Treatment Introduction
13.2.4 Novartis Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Myocardial Ischemia Treatment Introduction
13.3.4 AstraZeneca Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Boston Scientific
13.4.1 Boston Scientific Company Details
13.4.2 Boston Scientific Business Overview
13.4.3 Boston Scientific Myocardial Ischemia Treatment Introduction
13.4.4 Boston Scientific Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.4.5 Boston Scientific Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Myocardial Ischemia Treatment Introduction
13.5.4 Johnson & Johnson Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Details
13.6.2 Boehringer Ingelheim Business Overview
13.6.3 Boehringer Ingelheim Myocardial Ischemia Treatment Introduction
13.6.4 Boehringer Ingelheim Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.6.5 Boehringer Ingelheim Recent Development
13.7 Daiichi Sankyo
13.7.1 Daiichi Sankyo Company Details
13.7.2 Daiichi Sankyo Business Overview
13.7.3 Daiichi Sankyo Myocardial Ischemia Treatment Introduction
13.7.4 Daiichi Sankyo Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.7.5 Daiichi Sankyo Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Myocardial Ischemia Treatment Introduction
13.8.4 Merck Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Edwards Lifesciences
13.9.1 Edwards Lifesciences Company Details
13.9.2 Edwards Lifesciences Business Overview
13.9.3 Edwards Lifesciences Myocardial Ischemia Treatment Introduction
13.9.4 Edwards Lifesciences Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.9.5 Edwards Lifesciences Recent Development
13.10 Bayer
13.10.1 Bayer Company Details
13.10.2 Bayer Business Overview
13.10.3 Bayer Myocardial Ischemia Treatment Introduction
13.10.4 Bayer Revenue in Myocardial Ischemia Treatment Business (2015-2020)
13.10.5 Bayer Recent Development
13.11 Gene Biotherapeutics
10.11.1 Gene Biotherapeutics Company Details
10.11.2 Gene Biotherapeutics Business Overview
10.11.3 Gene Biotherapeutics Myocardial Ischemia Treatment Introduction
10.11.4 Gene Biotherapeutics Revenue in Myocardial Ischemia Treatment Business (2015-2020)
10.11.5 Gene Biotherapeutics Recent Development
13.12 ViroMed
10.12.1 ViroMed Company Details
10.12.2 ViroMed Business Overview
10.12.3 ViroMed Myocardial Ischemia Treatment Introduction
10.12.4 ViroMed Revenue in Myocardial Ischemia Treatment Business (2015-2020)
10.12.5 ViroMed Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Myocardial Ischemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Myocardial Ischemia Treatment Revenue
Table 3. Ranking of Global Top Myocardial Ischemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Myocardial Ischemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medications
Table 6. Key Players of Surgery
Table 7. Key Players of Others
Table 8. Global Myocardial Ischemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Myocardial Ischemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Myocardial Ischemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Myocardial Ischemia Treatment Market Share by Regions (2015-2020)
Table 12. Global Myocardial Ischemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Myocardial Ischemia Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Myocardial Ischemia Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Myocardial Ischemia Treatment Players
Table 19. Global Myocardial Ischemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Myocardial Ischemia Treatment Market Share by Players (2015-2020)
Table 21. Global Top Myocardial Ischemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myocardial Ischemia Treatment as of 2019)
Table 22. Global Myocardial Ischemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Myocardial Ischemia Treatment Product Solution and Service
Table 25. Date of Enter into Myocardial Ischemia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Myocardial Ischemia Treatment Market Size Share by Type (2015-2020)
Table 29. Global Myocardial Ischemia Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Myocardial Ischemia Treatment Market Size Share by Application (2015-2020)
Table 31. Global Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Myocardial Ischemia Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 35. North America Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 37. North America Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 41. Europe Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 43. Europe Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 47. China Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 49. China Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 53. Japan Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 55. Japan Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 59. Southeast Asia Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 65. India Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 67. India Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Myocardial Ischemia Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Myocardial Ischemia Treatment Market Share (2019-2020)
Table 71. Central & South America Myocardial Ischemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Myocardial Ischemia Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Myocardial Ischemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Myocardial Ischemia Treatment Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. AstraZeneca Company Details
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Product
Table 88. AstraZeneca Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 89. AstraZeneca Recent Development
Table 90. Boston Scientific Company Details
Table 91. Boston Scientific Business Overview
Table 92. Boston Scientific Product
Table 93. Boston Scientific Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 94. Boston Scientific Recent Development
Table 95. Johnson & Johnson Company Details
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson Product
Table 98. Johnson & Johnson Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 99. Johnson & Johnson Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Product
Table 103. Boehringer Ingelheim Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Daiichi Sankyo Company Details
Table 106. Daiichi Sankyo Business Overview
Table 107. Daiichi Sankyo Product
Table 108. Daiichi Sankyo Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 109. Daiichi Sankyo Recent Development
Table 110. Merck Business Overview
Table 111. Merck Product
Table 112. Merck Company Details
Table 113. Merck Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 114. Merck Recent Development
Table 115. Edwards Lifesciences Company Details
Table 116. Edwards Lifesciences Business Overview
Table 117. Edwards Lifesciences Product
Table 118. Edwards Lifesciences Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 119. Edwards Lifesciences Recent Development
Table 120. Bayer Company Details
Table 121. Bayer Business Overview
Table 122. Bayer Product
Table 123. Bayer Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 124. Bayer Recent Development
Table 125. Gene Biotherapeutics Company Details
Table 126. Gene Biotherapeutics Business Overview
Table 127. Gene Biotherapeutics Product
Table 128. Gene Biotherapeutics Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 129. Gene Biotherapeutics Recent Development
Table 130. ViroMed Company Details
Table 131. ViroMed Business Overview
Table 132. ViroMed Product
Table 133. ViroMed Revenue in Myocardial Ischemia Treatment Business (2015-2020) (Million US$)
Table 134. ViroMed Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myocardial Ischemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medications Features
Figure 3. Surgery Features
Figure 4. Others Features
Figure 5. Global Myocardial Ischemia Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Myocardial Ischemia Treatment Report Years Considered
Figure 11. Global Myocardial Ischemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Myocardial Ischemia Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Myocardial Ischemia Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Myocardial Ischemia Treatment Market Share by Players in 2019
Figure 16. Global Top Myocardial Ischemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myocardial Ischemia Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Myocardial Ischemia Treatment Revenue in 2019
Figure 18. North America Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Myocardial Ischemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

心筋虚血治療薬の世界市場（～2026年）

Global Myocardial Ischemia Drugs Market Insights and Forecast to 2026
MRC2-11QY07954 2020年11月20日 110Pages
当調査資料は心筋虚血治療薬のグローバル市場について調査・分析したレポートです。種類別（BAY-606583、CMK-103、DT-010、ヒューマニン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

心筋灌流イメージング（MPI）検査の世界市場（～2026年）

Global Myocardial Perfusion Imaging (MPI) Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY03888 2020年11月20日 97Pages
当調査資料は心筋灌流イメージング（MPI）検査のグローバル市場について調査・分析したレポートです。種類別（ストレス心筋灌流イメージング（MPI）、安静時心筋灌流イメージング（MPI））市場規模、用途別（病院、クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...

心筋血行再建・修復・再生製品・治療法の世界市場（～2026年）

Global Myocardial Revascularization, Repair, and Regeneration Products and Therapies Market Size, Status and Forecast 2020-2026
MRC2-11QY03889 2020年11月20日 91Pages
当調査資料は心筋血行再建・修復・再生製品・治療法のグローバル市場について調査・分析したレポートです。種類別（心筋血行再建術、アテローム性動脈硬化症管理技術、現在・新型心筋修復/再生技術）市場規模、用途別（病院、看護センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、...

クリティカルリム虚血治療薬の世界市場（～2026年）

Global Critical Limb Ischemia Drug Market Insights and Forecast to 2026
MRC2-11QY00746 2020年11月20日 117Pages
当調査資料はクリティカルリム虚血治療薬のグローバル市場について調査・分析したレポートです。種類別（HC-016、JVS-100、NFx-101、NK-104 NP、その他）市場規模、用途別（病院、在宅介護、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

心筋梗塞治療薬の世界市場（～2026年）

Global Myocardial Infarction Drug Market Insights and Forecast to 2026
MRC2-11QY07953 2020年11月20日 150Pages
当調査資料は心筋梗塞治療薬のグローバル市場について調査・分析したレポートです。種類別（JVS-200、KR-33028、AMRS-001、ANG-4011、バリクサフォルチド、CAP-1002、センデリチド、その他）市場規模、用途別（研究センター、病院、クリニック）市場規模、地域別（北米、米国、カナ...

高カルシウム血症治療の世界市場（～2026年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12275 2020年11月25日 95Pages
当調査資料は高カルシウム血症治療のグローバル市場について調査・分析したレポートです。種類別（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）市場規模、用途別（軽度高カルシウム血症、中等度高カルシウム血症、重度高カルシウム血症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

軟骨無形成症治療の世界市場（～2026年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13545 2020年11月30日 95Pages
当調査資料は軟骨無形成症治療のグローバル市場について調査・分析したレポートです。種類別（RBM-007、TA-46、B-701、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

交流電場腫瘍治療の世界市場（～2026年）

Global Alternating Electric Field Tumor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13660 2020年11月30日 97Pages
当調査資料は交流電場腫瘍治療のグローバル市場について調査・分析したレポートです。種類別（低周波、中周波）市場規模、用途別（病院、診療所、がん・放射線治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

静脈瘤治療の世界市場（～2026年）

Global Varicose Vein Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04979 2020年11月20日 96Pages
当調査資料は静脈瘤治療のグローバル市場について調査・分析したレポートです。種類別（アブレーション装置、高周波アブレーション装置、レーザーアブレーション装置、静脈閉鎖製品）市場規模、用途別（静脈内アブレーション、注射硬化療法、外科的結紮/剥離）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

心筋虚血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Myocardial Ischemia Drugs Market The global Myocardial Ischemia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Myocardial Ischemia Drugs Scope and Market Size Myocardial Isch…
心筋灌流イメージング（MPI）検査の世界市場（～2026年） Myocardial perfusion imaging is an imaging device which work non-invasively to show the blood flow, myocardial perfusion imaging also known as nuclear cardiology test. The main function of this imaging to show the blood flow to muscle of heart or myocardium and to identify the absence or presence of…
心筋血行再建・修復・再生製品・治療法の世界市場（～2026年） Market Analysis and Insights: Global Myocardial Revascularization, Repair, and Regeneration Products and Therapies Market The global Myocardial Revascularization, Repair, and Regeneration Products and Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at…
クリティカルリム虚血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Critical Limb Ischemia Drug Market The global Critical Limb Ischemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Critical Limb Ischemia Drug Scope and Market Size Critical …
心筋梗塞治療薬の世界市場（～2026年） Market Analysis and Insights: Global Myocardial Infarction Drug Market The global Myocardial Infarction Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Myocardial Infarction Drug Scope and Market Size Myocardial I…